Hearing News Watch

Featured image for “Future of Hearing Healthcare Conference Returns for 6th Year, Set for May 13, 20, and 27”
May. 02, 2026

Future of Hearing Healthcare Conference Returns for 6th Year, Set for May 13, 20, and 27

HHTM
The sixth annual Future of Hearing Healthcare Conference (FHH) will be held virtually on May 13, 20, and 27, continuing its focus on the ideas, innovations, and individuals shaping the future of hearing care. The popular three-day event will feature more than 23 expert-led sessions alongside panel discussions addressing clinical best practices, emerging technologies, research developments, and evolving models of
Featured image for “ADA, WSA and KAA Partner on Kentucky Hearing Health Awareness Campaign”
May. 01, 2026

ADA, WSA and KAA Partner on Kentucky Hearing Health Awareness Campaign

HHTM
As Better Hearing Month begins, the Academy of Doctors of Audiology (ADA), WS Audiology (WSA), and the Kentucky Academy of Audiology (KAA) have launched Listen Up Kentucky, a new public awareness initiative focused on prevention, early intervention, and the lifelong importance of hearing health. The campaign is designed as a state-level pilot to increase public awareness around the risks of
Featured image for “Elevated serotonin levels may worsen tinnitus by boosting activity in auditory brain regions”
Apr. 27, 2026

Elevated serotonin levels may worsen tinnitus by boosting activity in auditory brain regions

HHTM
PORTLAND, OREGON — New research from Oregon Health & Science University and Anhui University in China suggests that serotonin, a neurotransmitter commonly targeted by medications for depression and anxiety, may also play a role in worsening tinnitus symptoms. The study, published April 20 in the Proceedings of the National Academy of Sciences, found that elevated serotonin levels in the brain
Featured image for “Envoy Medical Announces Milestone as All 56 Patients Activated in Acclaim® Cochlear Implant Trial”
Apr. 25, 2026

Envoy Medical Announces Milestone as All 56 Patients Activated in Acclaim® Cochlear Implant Trial

HHTM
WHITE BEAR LAKE, MINNESOTA — Envoy Medical, Inc. (NASDAQ: COCH) announced that all 56 participants enrolled in its pivotal clinical trial evaluating the fully implanted Acclaim® cochlear implant have completed their activation visits, marking a key milestone in the study timeline. The activation visit represents the point at which each participant’s device is turned on for the first time. “With
Featured image for “Regeneron Secures Landmark FDA Approval for Hearing Loss Gene Therapy, Otarmeni™”
Apr. 23, 2026

Regeneron Secures Landmark FDA Approval for Hearing Loss Gene Therapy, Otarmeni™

HHTM
TARRYTOWN, NEW YORK — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Otarmeni™ (lunsotogene parvec-cwha), marking the first gene therapy approved for a genetic form of hearing loss. The approval represents a significant milestone for a field that has been steadily advancing in recent years. As previously discussed in
Featured image for “Dr. Brian Taylor: Why I Joined Neurotone AI”
Apr. 23, 2026

Dr. Brian Taylor: Why I Joined Neurotone AI

HHTM
Miracle-Ear conventions used to be raucous affairs, and their 2005 event in Huntington Beach, CA, was no exception. Beyond franchisees masquerading as USC Trojans while a Beach Boys cover band played hits from the early 1960s, one memorable moment from this conference sticks out for me: Robert Sweetow’s talk on something called “Listening and Communication Enhancement,” or LACE as he
Featured image for “World Record Adventurer Louis Alexander Urges Earlier Hearing Checks to Support Brain Health”
Apr. 23, 2026

World Record Adventurer Louis Alexander Urges Earlier Hearing Checks to Support Brain Health

HHTM
Three-time world record holder and dementia advocate Louis Alexander is calling for greater awareness of earlier ear and hearing health checks, amid growing concern about the links between hearing loss and cognitive decline. Hearing loss is the top modifiable risk factor for dementia, according to The Lancet Commission. However, a new study of more than 1,000 people conducted by ear
Featured image for “Phonak Partners with USA Pickleball to Expand Hearing Health Awareness”
Apr. 22, 2026

Phonak Partners with USA Pickleball to Expand Hearing Health Awareness

HHTM
AURORA, ILLINOIS — Phonak U.S. announced a new partnership with USA Pickleball as part of its nationwide “Hear to Win” campaign, an initiative focused on encouraging a more proactive approach to hearing health. The campaign aims to raise awareness of the role hearing plays in overall wellness, particularly in maintaining social connection and engagement. Through the partnership, Phonak will bring
Featured image for “Treble Health Expands In-Person Tinnitus Care with Silicon Valley Hearing Acquisition”
Apr. 21, 2026

Treble Health Expands In-Person Tinnitus Care with Silicon Valley Hearing Acquisition

HHTM
LOS GATOS, CALIFORNIA — Treble Health, a telehealth-first tinnitus and audiology practice, has acquired Silicon Valley Hearing, an audiology clinic based in Los Gatos, California. The acquisition expands Treble Health’s in-person presence into the San Francisco Bay Area and adds Silicon Valley Hearing’s clinical team to its network. Founded by Ben Thompson, AuD, Treble Health has developed a tinnitus-focused care
Featured image for “WSA Introduces Sound Preference Program to Enhance Personalized Hearing Care”
Apr. 20, 2026

WSA Introduces Sound Preference Program to Enhance Personalized Hearing Care

HHTM
WSA has announced the launch of its new Sound Preference program, a research-backed initiative designed to help hearing care professionals better understand how individual sound preferences influence hearing aid adoption and long-term satisfaction. The program combines new research, clinical tools, and educational resources aimed at integrating sound preference into the hearing aid fitting process—an area that has historically been guided